Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia

NCT01843634 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jazz Pharmaceuticals